Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anticoagulation Treatment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT07580937
What this trial is testing

Studying Heart Ablation After Left Atrial Closure in High-Bleeding-Risk Atrial Fibrillation Patients

Who this might be right for
Atrial FibrillationAtrial Arrhythmia
University of Chicago 198
Not applicableLooking for participantsNCT07801638
What this trial is testing

Anticoagulation Combined With Tocilizumab for Interleukin-6 Receptor Inhibition in Acute Cerebral Venous Thrombosis

Who this might be right for
Cerebral Venous Thrombosis
Capital Medical University 80
Post-approval studies (Phase 4)Study completedNCT01468155
What this trial is testing

DAPPAR AF Dabigatran for Peri Procedural Anticoagulation During Radiofrequency Ablation of Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 50
Post-approval studies (Phase 4)Study completedNCT00039858
What this trial is testing

Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin

Who this might be right for
ThrombocytopeniaThrombosis
Encysive Pharmaceuticals 24
Not applicableStudy completedNCT02068755
What this trial is testing

Blood Products in Cardiac Surgery

Who this might be right for
AnemiaRenal ImpairmentThrombocytopenia
University of Turku 31,000
Large-scale testing (Phase 3)Ended earlyNCT05172115
What this trial is testing

Catheter-Directed Thrombolysis Versus Anticoagulation Monotherapy in Intermediate-High Risk PE

Who this might be right for
Pulmonary EmbolismPulmonary ThromboembolismsEmbolism, Pulmonary+1 more
Rajaie Cardiovascular Medical and Research Center 94
Early research (Phase 1)Ended earlyNCT00288808
What this trial is testing

Comparison Between Point of Care Device and Venous Blood International Normalized Ratio Measurements.

Who this might be right for
Blood Coagulation Disorder
University of Rochester 200
Not applicableUnknownNCT03005444
What this trial is testing

Anticoagulation for Advanced Cirrhotic Patients After TIPS

Who this might be right for
Liver Cirrhosis
Air Force Military Medical University, China 254
Not applicableStudy completedNCT02211326
What this trial is testing

Genotype-guided Warfarin Individualized Treatment

Who this might be right for
Atrial FibrillationDeep Venous Thrombosis
The Third Xiangya Hospital of Central South University 660
Not applicableUnknownNCT03759938
What this trial is testing

OPTIMAS: OPtimal TIMing of Anticoagulation After Acute Ischaemic Stroke : a Randomised Controlled Trial

Who this might be right for
Stroke, AcuteAtrial Fibrillation
University College, London 3,648
Testing effectiveness (Phase 2)Study completedNCT02923115
What this trial is testing

Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary Embolism

Who this might be right for
Pulmonary EmbolismThrombotic Disease
Daiichi Sankyo 134
Large-scale testing (Phase 3)UnknownNCT00474591
What this trial is testing

Fondaparinux to Prevent Thrombotic Complications and Graft Failure in Patients Undergoing Coronary Artery Bypass Graft Surgery: The Fonda CABG Study

Who this might be right for
Coronary Bypass Graft Failure/Occlusion
Hamilton Health Sciences Corporation 100
Large-scale testing (Phase 3)Ended earlyNCT01204333
What this trial is testing

Thrombolysis or Anticoagulation for Cerebral Venous Thrombosis

Who this might be right for
Sinus Thrombosis, Intracranial
Jan Stam, MD, PhD 67
Not applicableUnknownNCT04462614
What this trial is testing

Possibility to Stop Perdialytic Heparin Therapy in Hemodialysed Patients With HeprAN ™ Membrane and Treated by Long-term Anticoagulation With VKA

Who this might be right for
Chronic HemolysisVKAAnticoagulants / Administration & Dosage+7 more
CHU de Reims 49
Post-approval studies (Phase 4)Study completedNCT00966290
What this trial is testing

Anticoagulant Clinics and Vitamin K Antagonists

Who this might be right for
Blood Coagulation Disorders
University Hospital, Toulouse 1,006
Post-approval studies (Phase 4)Study completedNCT03413618
What this trial is testing

Rivaroxaban With Diosmin in Long-term Treatment of Deep Vein Thrombosis

Who this might be right for
Deep Vein ThrombosisPostthrombotic Syndrome
Pirogov Russian National Research Medical University 90
Post-approval studies (Phase 4)Study completedNCT05191290
What this trial is testing

Comparison of Biocompatibility of Plasmapheresis Procedures With Citrate and Heparin Anticoagulation

Who this might be right for
ApheresisAnticoagulation
University Medical Centre Ljubljana 15
Not applicableEnded earlyNCT02928497
What this trial is testing

Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation

Who this might be right for
Stroke
Boston Scientific Corporation 481
Large-scale testing (Phase 3)Study completedNCT01166997
What this trial is testing

ULTrasound Accelerated ThrombolysIs of PulMonAry Embolism

Who this might be right for
Submassive Pulmonary Embolism
Boston Scientific Corporation 59
Not applicableUnknownNCT04364516
What this trial is testing

Retrospective Observational Registry of Patients With Atrial Fibrillation From Vigo´s Health Area

Who this might be right for
Atrial Fibrillation
Hospital Álvaro Cunqueiro 15,000
Next Page